Fig. 1.
Kaplan-Meier estimates of survival among patients treated with intravenous (IV) and subcutaneous (SC) tocilizumab. Long-rank test for intergroup differences in survival rate distribution P = 0.11.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.